Relay Therapeutics Inc
NASDAQ:RLAY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Relay Therapeutics Inc
NASDAQ:RLAY
|
US |
|
Simulations Plus Inc
NASDAQ:SLP
|
US |
|
B
|
Borgwarner Inc
F:BGW
|
US |
|
FRMO Corp
OTC:FRMO
|
US |
|
K
|
Kaspi.kz AO
F:KKS
|
KZ |
|
Oriental Aromatics Ltd
BSE:500078
|
IN |
|
F
|
Fuyo General Lease Co Ltd
TSE:8424
|
JP |
|
B
|
Beneficient
NASDAQ:BENF
|
US |
|
A
|
Aristocrat Leisure Ltd
XMUN:AC8
|
AU |
|
C
|
CapitaLand Integrated Commercial Trust
DUS:M3T
|
SG |
|
P
|
Prosus NV
OTC:PROSY
|
NL |
|
EPL Ltd
NSE:EPL
|
IN |
|
Activeops PLC
F:95D
|
UK |
|
Alsea SAB de CV
BMV:ALSEA
|
MX |
|
B
|
BW Energy Ltd
OSE:BWE
|
BM |
Shareholder Yield
Current shareholder yield for RLAY is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
RLAY Price
Relay Therapeutics Inc
| Average Annual Return | 17.56% |
| Standard Deviation of Annual Returns | 89.24% |
| Max Drawdown | -95% |
| Market Capitalization | 4.1B USD |
| Shares Outstanding | 215 560 000 |
| Percentage of Shares Shorted | 23.02% |
